Publications by authors named "A P Gay"

Understanding biological mechanisms underlying anorexia nervosa (AN) is necessary to develop care strategies. Despite many articles dedicated to peptides assessment in AN, there is no systematic review. A scoping review of circulating peptides published in relation to AN, comparing their results with those of controls, was conducted.

View Article and Find Full Text PDF

Introduction: The clinical landscape for the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D) is rapidly evolving. As part of the FOUNTAIN platform (NCT05526157; EUPAS48148), we described and compared cohorts of adult patients with CKD and T2D initiating a sodium-glucose cotransporter 2 inhibitor (SGLT2i) before the launch of finerenone in Europe, Japan, and the United States (US).

Methods: This was a multinational, multi-cohort study of patients with T2D in five data sources: the Danish National Health Registers (DNHR) (Denmark), PHARMO Data Network (The Netherlands), Valencia Health System Integrated Database (VID) (Spain), Japan Chronic Kidney Disease Database Extension (J-CKD-DB-Ex) (Japan), and Optum's de-identified Clinformatics Data Mart Database (CDM) (US).

View Article and Find Full Text PDF
Article Synopsis
  • Finerenone is a non-steroidal mineralocorticoid receptor antagonist that shows promise in improving kidney and cardiovascular health for patients with chronic kidney disease (CKD) related to type 2 diabetes (T2D), as highlighted in the ongoing FINE-REAL study.
  • The study, which started in June 2022 and will continue until January 2028, involves a diverse group of patients from different healthcare settings, with a total of 556 enrolled and a median follow-up of 7 months noted by the analysis cutoff on June 13, 2023.
  • Findings indicate that a significant percentage of patients were on other kidney-protective medications when starting fineren
View Article and Find Full Text PDF

Objective: Patients with type 2 diabetes (T2D) are at high risk for developing chronic kidney disease (CKD). The onset of incident CKD may complicate glycemic control among these patients. This study aimed to characterize antihyperglycemic medication use after incident CKD onset among patients with T2D to inform disease management.

View Article and Find Full Text PDF

Background: Infection is one of the main complications of hip and knee arthroplasties. Topical application vancomycin to prevent postoperative infections is efficient in spine surgery, and is spreading in prosthetic surgery. However, its clinical relevance and safety are still under debate.

View Article and Find Full Text PDF